Efficacy of Single-Dose Liposomal Amphotericin B or Micafungin Prophylaxis in a Neutropenic Murine Model of Invasive Pulmonary Aspergillosis

被引:21
|
作者
Lewis, Russell E. [1 ,2 ]
Albert, Nathaniel D. [1 ]
Kontoyiannis, Dimitrios P. [1 ,2 ]
机构
[1] Univ Houston, Coll Pharm, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
关键词
D O I
10.1128/AAC.00715-08
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
In a neutropenic murine model of invasive pulmonary aspergillosis, prophylaxis with single doses of liposomal amphotericin B or micafungin at >= 5 mg/kg of body weight improved animal survival and suppressed the lung fungal burden for up to 7 days after infection, demonstrating the potential utility of infrequent dosing with these antifungals.
引用
收藏
页码:4178 / 4180
页数:3
相关论文
共 50 条
  • [1] Efficacy of liposomal amphotericin B for prophylaxis of acute or reactivation models of invasive pulmonary aspergillosis
    Leleu, Christopher
    Menotti, Jean
    Meneceur, Pascale
    Choukri, Firas
    Sulahian, Annie
    Garin, Yves J. -F.
    Derouin, Francis
    [J]. MYCOSES, 2013, 56 (03) : 241 - 249
  • [2] Efficacy of Combination Antifungal Therapy with Intraperitoneally Administered Micafungin and Aerosolized Liposomal Amphotericin B against Murine Invasive Pulmonary Aspergillosis
    Takazono, Takahiro
    Izumikawa, Koichi
    Mihara, Tomo
    Kosai, Kosuke
    Saijo, Tomomi
    Imamura, Yoshifumi
    Miyazaki, Taiga
    Seki, Masafumi
    Kakeya, Hiroshi
    Yamamoto, Yoshihiro
    Yanagihara, Katsunori
    Kohno, Shigeru
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (08) : 3508 - 3510
  • [3] Single-dose AmBisome (liposomal amphotericin B) as prophylaxis for murine systemic candidiasis and histoplasmosis
    Garcia, A
    Adler-Moore, JP
    Proffitt, RT
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (09) : 2327 - 2332
  • [4] Comparative Study on the Efficacy of Liposomal Amphotericin B and Voriconazole in a Murine Pulmonary Aspergillosis Model
    Takemoto, Koji
    Yamamoto, Yutaka
    Ueda, Yutaka
    Kanazawa, Katsunori
    Yoshida, Koichiro
    Niki, Yoshihito
    [J]. CHEMOTHERAPY, 2009, 55 (02) : 105 - 113
  • [5] Combination antifungal therapy of murine aspergillosis: liposomal amphotericin B and micafungin
    Graybill, JR
    Bocanegra, R
    Gonzalez, GM
    Najvar, LK
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (04) : 656 - 662
  • [6] Efficacy of SPK-843, a novel polyene antifungal, in comparison with amphotericin B, liposomal amphotericin B, and micafungin against murine pulmonary aspergillosis
    Kakeya, Hiroshi
    Miyazaki, Yoshitsugu
    Senda, Hisato
    Kobayashi, Tsutomu
    Seki, Masafumi
    Izumikawa, Koichi
    Yanagihara, Kazunori
    Yamamoto, Yoshihiro
    Tashiro, Takayoshi
    Kohno, Shigeru
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (05) : 1868 - 1870
  • [7] A Case of Refractory Pulmonary Aspergillosis Treated with Micafungin and Liposomal Amphotericin B
    Lodhi, W.
    Ghimirey, N.
    Wajahat, R.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [8] The iron chelator deferasirox enhances liposomal amphotericin B efficacy in treating murine invasive pulmonary aspergillosis
    Ibrahim, Ashraf S.
    Gebremariam, Teclegiorgis
    French, Samuel W.
    Edwards, John E., Jr.
    Spellberg, Brad
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (02) : 289 - 292
  • [9] Efficacy of voriconazole plus amphotericin B or micafungin in a guinea-pig model of invasive pulmonary aspergillosis
    Chandrasekar, PH
    Cutright, JL
    Manavathu, EK
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2004, 10 (10) : 925 - 928
  • [10] Aerosolized Liposomal Amphotericin B: A Potential Prophylaxis of Invasive Pulmonary Aspergillosis in Immunocompromised Patients
    Kamalaporn, Harutai
    Leung, Kitty
    Nagel, Mark
    Kittanakom, Saranya
    Calvieri, Battista
    Reithmeier, Reinhart A. F.
    Coates, Allan L.
    [J]. PEDIATRIC PULMONOLOGY, 2014, 49 (06) : 574 - 580